
1.9BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
3.13
Dividend Share
-
Dividend Yield
-
Earnings Share
-10.06
Wall Street Target Price
47.88
EPS Estimate Current Year
-5.62
EPS Estimate Next Year
-4.82
EPS Estimate Current Quarter
-1.27
EPS Estimate Next Quarter
-1.28
Most Recent Quarter
-
Revenue TTM
11,000,000
Gross Profit TTM
-226,546,000
EBITDA
-302,206,016
Profit Margin
0.00%
Return On Assets TTM
-37.88%
Return On Equity TTM
-265.11%
Revenue Per Share TTM
0.185
Qtly Revenue Growth YOY
-100.00%
Diluted Eps TTM
-10.06
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
172.1955
Price Book MRQ
8.8948
Enterprise Value Revenue
141
Enterprise Value EBITDA
0
208.70
1.01%947.36
0.18%965.00
0.00%136.78
0.00%327.34
-2.89%158.00
-2.19%33.47
-1.56%406.04
-1.51%531.01
-0.55%953.05
-0.39%